| Mar 5, 2025 |
Mar 7, 2025 |
Tenaya Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+35,714,284
|
262.62%
|
✗
|
$25M |
| Feb 12, 2024 |
Feb 14, 2024 |
Tenaya Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+2,222,222
|
19.53%
|
✗
|
$10M |
| Mar 10, 2023 |
Mar 14, 2023 |
Tenaya Therapeutics, Inc.
|
Director |
Buy |
56.3
|
+6,779
|
0.06%
|
✗
|
$17.6K |
| Feb 8, 2023 |
Feb 10, 2023 |
Tenaya Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+1,500,000
|
15.20%
|
✗
|
$3.9M |
| Jan 19, 2023 |
Jan 23, 2023 |
Tenaya Therapeutics, Inc.
|
Director |
Buy |
65.0
|
+69,739
|
0.36%
|
✗
|
$174.2K |
| Jan 17, 2023 |
Jan 19, 2023 |
Tenaya Therapeutics, Inc.
|
Director |
Buy |
85.0
|
+185,151
|
1.93%
|
✗
|
$464.8K |
| Nov 21, 2022 |
Nov 23, 2022 |
Tenaya Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+9,615,384
|
100.00%
|
✗
|
$25M |
| May 25, 2022 |
May 27, 2022 |
RAPT Therapeutics, Inc.
|
10% Owner |
Buy |
56.3
|
+1,900
|
0.07%
|
✗
|
$23.7K |
| May 23, 2022 |
May 25, 2022 |
RAPT Therapeutics, Inc.
|
10% Owner |
Buy |
75.0
|
+26,550
|
0.68%
|
✗
|
$323.7K |
| May 10, 2022 |
May 12, 2022 |
RAPT Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+1,250,000
|
39.72%
|
✗
|
$13.3M |
| Sep 27, 2021 |
Sep 29, 2021 |
RAPT Therapeutics, Inc.
|
10% Owner |
Sell |
30.0
|
-9,239
|
-0.65%
|
✗
|
$319.4K |
| Sep 14, 2021 |
Sep 16, 2021 |
RAPT Therapeutics, Inc.
|
10% Owner |
Sell |
16.3
|
-181,211
|
-9.66%
|
✗
|
$6.7M |
| Sep 10, 2021 |
Sep 14, 2021 |
RAPT Therapeutics, Inc.
|
10% Owner |
Sell |
17.5
|
-985,383
|
-30.21%
|
✗
|
$1.3M |
| Sep 1, 2021 |
Sep 3, 2021 |
RAPT Therapeutics, Inc.
|
10% Owner |
Sell |
17.5
|
-68,850
|
-2.52%
|
✗
|
$2.4M |
| Aug 20, 2021 |
Aug 24, 2021 |
RAPT Therapeutics, Inc.
|
10% Owner |
Sell |
17.5
|
-95,746
|
-2.90%
|
✗
|
$3M |
| Nov 16, 2020 |
Nov 18, 2020 |
Revolution Medicines, Inc.
|
10% Owner |
Sell |
15.0
|
-2,027,156
|
-30.68%
|
✗
|
$73.8M |
| Sep 22, 2020 |
Sep 23, 2020 |
RAPT Therapeutics, Inc.
|
10% Owner |
Sell |
15.0
|
-608,000
|
-13.68%
|
✗
|
$18.8M |
| Aug 17, 2020 |
Aug 19, 2020 |
RAPT Therapeutics, Inc.
|
10% Owner |
Sell |
15.0
|
-538,654
|
-10.81%
|
✗
|
$12.3M |
| Nov 4, 2019 |
Nov 4, 2019 |
RAPT Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+625,000
|
14.18%
|
✗
|
$7.5M |